Person stretching
·
3 Min Read

What every U.S. employer can do to help end the overdose epidemic

The nation saw a record-high tally of drug-overdose deaths during the pandemic. Employers play a vital role in prevention. Learn more with the AMA.

Behavioral Health
Naloxone spray
·
3 Min Read

Biden administration boosts access to overdose prevention, treatment

The drug-overdose epidemic continues during the COVID-19 pandemic, but steps are being taken that will save lives and enhance access to treatment.

Behavioral Health
·
3 Min Read

May 21, 2021: State Advocacy Update

Sterile needle and syringe exchange bill headed to Arizona governor and more in the latest State Advocacy Update.

Advocacy Update
·
9 Min Read

May 7, 2021: National Advocacy Update

New program covering the cost of administering COVID-19 vaccines and more in the latest National Advocacy Update.

Advocacy Update
·
1 Min Read

AMA statement on FDA decision on naloxone nasal

AMA commends FDA’s approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.

Press Releases
·
4 Min Read

8 keys to end the nation’s drug-overdose epidemic

The CDC is reporting a record-breaking annual toll of nearly 90,000 U.S. overdose deaths. Learn about the policy steps needed to stem the tide.

Behavioral Health
·
2 Min Read

AMA presents Government Service Award to public health champion

Dr. Baird has dedicated his life to improving community health, and people across North Dakota have benefited from his tenacity, giving and dedication.

Press Releases
UPDATED
·
5 Min Read

COVID-19 policy recommendations for OUD, pain, harm reduction

Download guidance and issue brief PDFs—the AMA provides policy recommendations to help guide policymakers to reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.

series
Infectious Diseases
AMA COVID-19 Guides
·
4 Min Read

Policy road map shows the way to end the overdose epidemic

It’s been clear for years that, to end the drug overdose epidemic, health insurance company and pharmacy benefit managers’ barriers to evidence-based treatment and non-opioid pain management must be eliminated.

Behavioral Health